Navigation Links
EndoGastric Solutions(TM) Announces Results of EsophyX(TM) Multi-Center GERD Study
Date:2/26/2008

ontinuous improvement and are already teaching a much improved TIF 2 technique in our training center in Redmond, Washington that has shown even stronger outcomes. We are encouraged that surgeons and advanced surgical endoscopists are rapidly adopting these new incisionless procedures, as patients are demanding a permanent solution for their reflux disease in the face of failing pharmacological therapy."

About EndoGastric Solutions

EndoGastric Solutions (EGS) is a privately held corporation located in Redmond, Washington and Redwood City, California. EGS is a pioneer in developing incisionless transoral procedures for the treatment of upper gastrointestinal diseases, including gastroesophageal reflux disease (GERD) and other GI conditions. EsophyX and StomaphyX(TM) are cleared by the FDA for specific indications, are CE marked, and are available for sale in the U.S. and Europe.

For more information about EndoGastric Solutions, Inc., EsophyX(TM) and StomaphyX(TM), please visit:

US: http://www.endogastricsolutions.com

EU: http://www.egseurope.eu

Other locations: http://www.egsglobal.net

For more information about the Ohio State University Medical Center Leap into the Future with Advances in Transoral Foregut Surgery course please visit: http://www.cmis.ohio-state.edu

Contact Information:

Press Contact:

Adrianna Tozzi

650-868-4587

atozzi@endogastricsolutions.com

US Physician Contact:

Karina Alcala

650-743-6353

Kalcala@endogastricsolutions.com

European Customer Contact:

Karl Blohm

General Manager, Europe


'/>"/>
SOURCE EndoGastric Solutions Inc.
Copyright©2008 PR Newswire.
All rights reserved

5

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... LOVELAND, Colo. , May 24, 2013  Heska Corporation ... veterinary diagnostic and specialty products, announced today that Dr. ... executive officer, and Jason Napolitano , executive ... Second Annual Marcum MicroCap Conference, which is being held May ... at the Grand Hyatt Hotel. The Company,s ...
(Date:5/24/2013)... 24, 2013 The potential of ... delivery of therapeutic agents has been receiving undeniable attention ... showing significant promise. The crucial formulation considerations for orally ... play a major role in the efficiency of pulmonary ... development of new formulation techniques and devices in recent ...
(Date:5/23/2013)... 2013 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... President and Chief Executive Officer of Neurocrine Biosciences, will be ... Health Care Conference in Boston.   The live ... Eastern Time / 8:20 a.m. Pacific Time.  The presentation will ... at http://www.neurocrine.com . If you are ...
Breaking Medicine Technology:Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2
... is pleased to announce that Dr. Andrea Zobel has ... CTD Operations.  In this capacity she will assume responsibility ... operated Clinical Trial Depots once they are ... relationship with their affiliate depot network. (Logo:  ...
... 2012 What:   Life Technologies Unveils ... (CES) in Las Vegas.  The Ion Proton™ Sequencer is designed ... When:   Tuesday, January 10th thru Friday, ... Where:   Las Vegas Convention Center, North Hall, Booth #3438 ...
Cached Medicine Technology:Marken Strengthens Clinical Trial Distribution Capabilities 2
(Date:5/25/2013)... May 25, 2013 A disorder of ... of peripheral neuropathy. According to neuropathy expert doctor Helen ... is estimated that the disorder affects almost 50% of ... arising from Diabetes. The high blood sugar levels in ... patients suffering from it usually tend to have abnormally ...
(Date:5/25/2013)... May 25, 2013 Radius Engineering ... shelter company in the US and has been ... for over 35 years. M.E. and President, Walton ... of NBC Weapon Fundamentals and Shelter Engineering Standards, ... bible on shelter engineering. McCarthy is considered the ...
(Date:5/25/2013)... May 25, 2013 Pradaxa lawsuits ... life-threatening episodes of internal bleeding while using the blood thinner ... District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. ... Pradaxa side effect claims had been filed in ... from 705 claims reported by the Court on May 15th. ...
(Date:5/25/2013)... Many orthodontists have thought about moving ... that cloud is. Most people would naturally assume ... provide their cloud service and support would own and ... they're selling, they'd be wrong. Cloud providers lease ... redundant facility that houses servers and related equipment to ...
(Date:5/25/2013)... CA (PRWEB) May 25, 2013 IBISWorld estimates ... grow at an average annual rate of 28.7% to $1.0 ... 17.9% in 2013. From 2002 and 2008, no new cell ... Culbert, causing relatively modest growth during that period. In the ... approved six new products. This factor contributed to the industry's ...
Breaking Medicine News(10 mins):Health News:Diabetic Neuropathy treatment hits new grounds- Neuracel launches the complete natural treatment 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 2Health News:Pradaxa Lawsuits Mount, as Filings in Federal Pradaxa Side Effect Litigation Exceed 800, Bernstein Liebhard LLP Reports 3Health News:Cirrus Ortho Launches Cloud Computing for Orthodontic Industry That is Unlike Any Other 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Slow Healing: Cell Therapy in the US Industry Market Research Report Now Available from IBISWorld 3
... , Cancer Treatment Centers ... from Italy , PHILADELPHIA, Nov. 18 A radiation ... to the current average of six weeks, has arrived at ... CTCA will become the first in the country to offer this ...
... , , NEW YORK, Nov. ... kids, featuring reviews and commentary about products, discoveries on the ... kids behind WAT,s-THE-WORD?! are four young boys who helped their ... Cameron, age 10, recommended to his mom a "cooler" and ...
... , AUSTIN, Texas, Nov. 18 The Advisory Board of ... launch of a new online community for athletes overcoming accident, ... forum where athletes can share stories, set goals and report ... by providing encouragement, advice and mentoring. , IWillAgain.com is inspired ...
... , CALGARY, Nov. 18 /PRNewswire-FirstCall/ - Oncolytics ... announced today that it has entered into an underwriting agreement ... common share and 0.4 of a common share purchase warrant, ... proceeds of US$12,750,000. Each whole common share purchase warrant entitles ...
... , , WASHINGTON, Nov. 18 ... a wholly owned subsidiary of ULLICO Inc., a privately ... Prescription Solutions will provide pharmacy benefit management services to ... union trust funds, union employers and their members with ...
... 300 million patients use non-steroidal anti-inflammatory drugs (NSAIDs) in ... diseases. Nearly 30% of the users suffer from gastric ... the stomach, misoprostol, a non-selective prostaglandin E1 (PGE1) analogue, ... of NSAID-induced injuries, but often induces severe adverse effects. ...
Cached Medicine News:Health News:Radiation Breakthrough Gives Breast Cancer Patients Hope in Single Dose 2Health News:Radiation Breakthrough Gives Breast Cancer Patients Hope in Single Dose 3Health News:WAT-AAH!, The First Functional Bottled Water For Kids, Announces The Release of WAT's-THE-WORD?! 2Health News:IWillAgain.com Launches Online Community for Athletes Overcoming Accident, Illness or Injury 2Health News:Oncolytics Biotech(R) Inc. Announces Terms of Unit Offering 2Health News:Oncolytics Biotech(R) Inc. Announces Terms of Unit Offering 3Health News:Oncolytics Biotech(R) Inc. Announces Terms of Unit Offering 4Health News:Union Labor Life Selects Prescription Solutions To Provide Pharmacy Benefit Management Services 2Health News:Union Labor Life Selects Prescription Solutions To Provide Pharmacy Benefit Management Services 3
... Leptin is a proteohormone with a molecular weight ... by the ob gene and produced by adipocytes [1,2]. ... in the regulation of body weight [1-3]. In ... in both men and women [4]. A relationship ...
ACTIVATED CLOTTING TIME SYSTEM...
... CT is a completely automated, ... performing clotting assays in random ... method of sample management offers ... of STAT samples without the ...
... ACTH (adrenocorticotropic hormone) is synthesized in the ... and is secreted into the peripheral circulation, ... 20 minutes [1]. ACTH is secreted in ... hypothalamus [1]. The actions of CRF are ...
Medicine Products: